Crispr « Search Results « Science and Enterprise

Crispr Licensed for Eye Disease Gene Therapies

By Alan, on October 13th, 2021%

A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies

Trial Underway for Crispr Lymphoma Therapy

By Alan, on July 12th, 2021%

A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr. . . . → Read More: Trial Underway for Crispr Lymphoma Therapy

Trial Shows In-Body Crispr Therapy Feasibility

By Alan, on June 28th, 2021%

Early clinical trial data show gene editing with Crispr performed inside the body can correct an inherited neurological condition, with few adverse effects. . . . → Read More: Trial Shows In-Body Crispr Therapy Feasibility

Biotechs Partner on Crispr Therapies for Neuro Disorders

By Alan, on June 15th, 2021%

Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders

Crispr Treatment Leads to Durable Cholesterol Reduction

By Alan, on May 19th, 2021%

A developer of gene editing for inherited heart disease reports lab monkeys given its therapy experience lower cholesterol levels for at least eight months. . . . → Read More: Crispr Treatment Leads to Durable Cholesterol Reduction

Graphene Crispr Chip Detects Small Genetic Differences

By Alan, on April 5th, 2021%

An academic-industry team designed a computer chip with graphene circuits using the gene-editing technique Crispr to detect fine genetic differences in samples. . . . → Read More: Graphene Crispr Chip Detects Small Genetic Differences

Trial to Test Direct Crispr Blood Stem Cell Edits

By Alan, on March 31st, 2021%

A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease. . . . → Read More: Trial to Test Direct Crispr Blood Stem Cell Edits

Crispr Enables Inhaled Flu, Covid-19 Treatment

By Alan, on March 5th, 2021%

A biomedical engineering lab designed and tested in lab animals gene-edited therapies for influenza and Covid-19, inhaled by patients with a home device. . . . → Read More: Crispr Enables Inhaled Flu, Covid-19 Treatment

Crispr-Edited Bananas Get Industry Funding

By Alan, on February 18th, 2021%

A popular type of banana, genetically edited to resist a soil fungus that threatens this fruit worldwide, is now backed by a major American food brand. . . . → Read More: Crispr-Edited Bananas Get Industry Funding

AbbVie Licenses Engineered Crispr Cell Process

By Alan, on February 10th, 2021%

Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise